NANOPARTICULATE SYSTEM FOR EFFECTIVE TREATMENT OF TROPICAL DISEASES SUCH AS LEISHMANIASIS AND LYMPHATIC FILARIASIS
Journal Title: WORLD JOURNAL PHARMACY AND PHARMACEUTICAL SCIENCE - Year 2019, Vol 8, Issue 2
Abstract
Neglected tropical-- diseases (NTD) like lymphatic filariasis and leishmaniasis is a kind of parasitic diseases which affects humans after exposure towards ecosystems where the carriers, vectors and reservoirhost coexists. Lymphatic filariasis (LF) is a type of the neglected tropical disease caused by filarial nematode category parasites, Brugia timori, Brugia malayi, and Wuchereria bancrofti. Leishmaniasis is also a non-contagious vector-borne parasitic disease comes from the flagellated protozoans of the genus belongs to Leishmania that appear to exert pathological conditions. They often diffuses through the prick of infected sand flies called phlebotomies. The nature and character of these diseases is seeming to be more predominant especially in tropical area (ranging from 23.50 north to 23.50 south of the equator) and sub-tropical regions (area expands from 23.50 to 490 north and south result in to humid sub-tropical and dry summer). The disease has high rates of morbidity (rate of disease in population) and mortality (rate of death in population) all over the globe. The conventional drugs therapy are not very much effective due to improper bioavailability and its severe toxicity, hence novel strategy in developments of nanoparticle material have been introduced to accelerate effective and appropriate treatment towards neglected diseases along with lesser risk toxicity, suitable efficacy and enhancement in limited proportion in bioavailability. This review will focus on recent situation of nanoparticulate system in treatment against neglected diseases and also elaborated, how it contributes fundamental character to investigate new perspectives and challenges in approaching the homogenous treatment relevant to particular parasitic diseases.
Authors and Affiliations
Dr. Satya Prakash Singh
Keywords
Related Articles
- EP ID EP667267
- DOI -
- Views 139
- Downloads 0
COMPARATIVE HPLC STUDY OF RELEASE KINETICS OF THE COCRYSTALLIZED AS WELL AS MIXTURE OF ACTIVE PHARMACEUTICAL INGREDIENTS OF ASPIRIN, IBUPROFEN, INDOMETHACIN, DICLOFENAC SODIUM AND PARACETAMOL IN BODY FLUIDS
Aspirin, Ibuprofen, Indomethacin, Diclofenac sodium and Paracetamol are taken as NSAIDs. All drugs have free carboxylic acid group (–COOH) and paracetamol has free phenolic group (–OH) so all are acidic in nature. The co...
HOLD TIME STUDY FOR HARD GELATINE CAPSULES DURING MANUFACTURING PROCESS: A REVIEW
Stability studies plays major role in the pharmaceutical industry. Guidelines to conduct Stability studies for pharmaceutical drug products are available in ICH, USFDA, EMEA, WHO guidelines. It is important to perform th...
INTRALESIONAL TRIAMCINOLONE ACETONIDE INJECTION AS A TREATMENT OF CHALOZION VERSUS SURGICAL EVACUATION
Chalazion is a frequently encountered eyelid problem in the ophtharnic clinic. It is a chronic sterile lipogranulomatous inflammatory lesion caused by retained sebaceous secretion leaking from meibiomion gland or other s...
THEORETICAL STUDY OF THE STRUCTURE AND REACTIVITY DESCRIPTORS OF SULFAMIDES DERIVATIVES (SULFACETAMIDE, SULFAGUANIDINE, SULFAMETHOXAZOLE AND SULFATHIAZOLE)
In this report a complete theoretical calculations of (sulfacetamide, sulfaguanidine, sulfamethoxazole and sulfathiazole) 1-4 were performed by using Density Functional Theory (DFT) method with 6-31G (d,p) basis set. The...
A REVIEW ON PHARMACOLOGICAL ASPECTS OF MILK THISTLE
Milk thistle is also known as Silybum marianum (Compositae) is widespread throughout the world has been used for the treatment of liver diseases. Its common name comes from the white markings on the leaves and its milky...